Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析

◆英語タイトル:Taiwan Liposome Co Ltd (4152) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140156FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult advanced malignancies, soft tissue sarcoma and pediatric rhabdomyosarcoma. TLC holds expertise in lipid-based formulation and scale-up of parental drugs from nanoparticles for optimizing the pharmacokinetics of drugs. The company also develops BioSeizer lipid formulation technology and NanoX active drug loading technology. Its products find applications in the therapeutic areas of oncology, ophthalmology and oncology. The company has operations in Taiwan, the US, Japan and the Netherlands. TLC is headquartered in Taipei, Taiwan.

Taiwan Liposome Co Ltd Key Recent Developments

Feb 05,2021: TLC reports fiscal year end 2020 financial results and provides business update
Dec 18,2020: TLC provides corporate update at investor conference
Oct 28,2020: TLC reports third quarter 2020 financial results and provides business update
Oct 21,2020: TLC announces the appointment of Thomas H. Bliss, Jr., MBA, as chief business officer
Aug 05,2020: TLC reports second quarter 2020 financial results and provides business update

This comprehensive SWOT profile of Taiwan Liposome Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Taiwan Liposome Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Taiwan Liposome Co Ltd – Key Information
Taiwan Liposome Co Ltd – Overview
Taiwan Liposome Co Ltd – Key Employees
Taiwan Liposome Co Ltd – Key Employee Biographies
Taiwan Liposome Co Ltd – Key Operational Heads
Taiwan Liposome Co Ltd – Major Products and Services
Taiwan Liposome Co Ltd – History
Taiwan Liposome Co Ltd – Company Statement
Taiwan Liposome Co Ltd – Locations And Subsidiaries
Taiwan Liposome Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Taiwan Liposome Co Ltd – Business Description
Taiwan Liposome Co Ltd – Corporate Strategy
Taiwan Liposome Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Taiwan Liposome Co Ltd – Strengths
Taiwan Liposome Co Ltd – Weaknesses
Taiwan Liposome Co Ltd – Opportunities
Taiwan Liposome Co Ltd – Threats
Taiwan Liposome Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Taiwan Liposome Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Taiwan Liposome Co Ltd, Key Information
Taiwan Liposome Co Ltd, Key Ratios
Taiwan Liposome Co Ltd, Share Data
Taiwan Liposome Co Ltd, Major Products and Services
Taiwan Liposome Co Ltd, History
Taiwan Liposome Co Ltd, Key Employees
Taiwan Liposome Co Ltd, Key Employee Biographies
Taiwan Liposome Co Ltd, Key Operational Heads
Taiwan Liposome Co Ltd, Other Locations
Taiwan Liposome Co Ltd, Subsidiaries
Taiwan Liposome Co Ltd, Key Competitors
Taiwan Liposome Co Ltd, SWOT Analysis
Taiwan Liposome Co Ltd, Ratios based on current share price
Taiwan Liposome Co Ltd, Annual Ratios
Taiwan Liposome Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Russian Standard Bank:企業の戦略・SWOT・財務情報
    Russian Standard Bank - Strategy, SWOT and Corporate Finance Report Summary Russian Standard Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Rallis India Ltd (RALLIS):企業の財務・戦略的SWOT分析
    Summary Rallis India Ltd (Rallis), a subsidiary of Tata Chemicals Ltd, is an agri-solutions service provider. The company’s business portfolio includes domestic crop protection, international business, contract manufacturing, seeds, plant growth nutrients and agri services. Its products portfolio in …
  • AxoGen Inc (AXGN):医療機器:M&Aディール及び事業提携情報
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • Exxon Mobil Corporation (XOM)-エネルギー分野:企業M&A・提携分析
    Summary Exxon Mobil Corporation (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufactu …
  • Wexford Health Sources Inc:企業の戦略的SWOT分析
    Wexford Health Sources Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ricoh Imaging Co Ltd:企業の戦略的SWOT分析
    Ricoh Imaging Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Havells India Ltd (HAVELLS):企業の財務・戦略的SWOT分析
    Havells India Ltd (HAVELLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Genting Berhad:戦略・SWOT・企業財務分析
    Genting Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Beazer Homes USA Inc:企業の戦略・SWOT・財務情報
    Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bangchak Corporation PCL (BCP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bangchak Corporation PCL (Bangchak) is an integrated energy company. Its core business is petroleum refining, procuring crude oil from domestic and international sources and refining it into various petroleum products. The company’s major products include gasoline, gasohol, jet fuel, diesel, …
  • Suelopetrol CA SACA:企業の戦略的SWOT分析
    Suelopetrol CA SACA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system an …
  • Bionik Laboratories Corp (BNKL):企業の財務・戦略的SWOT分析
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company offers rehabilitation technology that senses patient movements and limitations. It provides lower body e …
  • Sunesis Pharmaceuticals Inc (SNSS):企業の財務・戦略的SWOT分析
    Sunesis Pharmaceuticals Inc (SNSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Mindax Limited:企業の戦略・SWOT・財務情報
    Mindax Limited - Strategy, SWOT and Corporate Finance Report Summary Mindax Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Kineta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Orpak Systems Limited:企業の戦略的SWOT分析
    Orpak Systems Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆